Transcription
ACS 2014 ENTREPRENEUR SUMMITDRAFTNational Education Association American Chemical Society Washington, DCOctober 13-14, 2014Theme: Customer FocusProvide entrepreneurs with a deeper understanding of commercialization challenges and the interplay between start-ups, government,financiers, and partners toward the successful commercialization of chemistry-based technologies.DAY 1 – Wednesday, October 13, 2014National Education Association Auditorium1201 16th Street, NW Washington DC 20036-32907:00AM – 8:15AMRegistration (Lobby)/Continental Breakfast8:15AM – 8:20AMSummit Opening & Welcoming RemarksACS’s Executive Director & CEO, Madeleine Jacobs, will open the Summit with welcoming remarks.8:20AM – 8:30AMSummit Overview & Keynote IntroductionACS’s Entrepreneurial Initiative Program Director, Dr. David Harwell, will provide an overview of the ACSEntrepreneurial Resources Center, the Summit, and introduce today’s keynote speaker, Dr. Carl J. Schramm.8:30AM – 9:30AMKeynote SpeakerAn internationally recognized leader in entrepreneurship, innovation and economic growth, Dr. Schramm willdiscuss changing paradigms in entrepreneurship and the emerging emphasis on customer needs.Dr. Carl J. Schramm, Professor at Syracuse University, former President of the Ewing Marion KauffmanFoundation9:30AM – 10:00AMBREAK & NETWORKING (NEA Auditorium Foyer)10:00AM – 11:00AMMinorities in Entrepreneurship – What’s NextThis session focuses on the achievements and challenges facing minority chemical entrepreneurs. Dr. McCrarywill discuss what lies ahead for their greater success.Dr. Victor McCrary, Vice President for Research and Development, Morgan State University11:00AM – 12:00PMWomen in Entrepreneurship – the Diana Project
ACS Executive Director & CEO, Madeleine Jacobs, interviews Dr. Greene about the progress that has beenmade and the remaining challenges facing women and minorities in entrepreneurship.Dr. Patricia G. Greene, Paul T. Babson Chair in Entrepreneurial Studies at Babson College and NationalAcademic Director for Goldman Sachs 10,000 Small Businesses initiative12:00PM – 1:30PMNETWORKING LUNCH (ACS Hach Headquarters – Marvel Halls)01:30PM – 2:30PMI-Corps – What’s NextThe NSF Innovation Corps (I-Corps ) is a set of activities and programs that prepare scientists and engineersto extend their focus beyond the laboratory and broaden the impact of selected, NSF-funded, basic-researchprojects. Combining experience and guidance from established entrepreneurs with a targeted curriculum, ICorps is a public-private partnership program that teaches grantees to identify valuable productopportunities that can emerge from academic research, and offers entrepreneurship education to faculty andstudent participants. This session will provide an overview of the I-Corps program and its accomplishmentsto date.Dr. Grace Wang, Deputy Assistant Director, Directorate for Engineering, National Science FoundationGrace Wang was named Deputy Assistant Director for Engineering at the National Science Foundation inJuly 2014. Prior to that, Grace was the Division Director of the Division of Industrial Innovation andPartnerships (IIP) at NSF since February 2012. Grace joined NSF in June 2009 as a Program Director forthe SBIR/STTR Program. She also served as the Cluster Leader for the Nanotechnology, AdvancedMaterials and Manufacturing (NM) Cluster in SBIR/STTR Program. Before joining NSF, Grace was a SeniorDevelopment Scientist at Hitachi, where she led a team to successfully develop and launch a few generationsof products into the market. While in Hitachi, Grace also led task forces both in the US and overseas thatidentified and executed effective and viable solutions to major technical crises, and helped mitigate impact onrevenue generation. Grace started her career as an Advisory Development Scientist at IBM. Grace is therecipient of many leadership and technical achievement awards. Grace holds a Ph.D. in Materials Science and Engineering fromNorthwestern University.Dr. Rathindra DasGupta, Program Director, Innovation Corps (I-Corps), National Science FoundationDr. DasGupta joined the National Science Foundation (NSF) in June 2006 as a Program Director in theDivision of Industrial Innovation and Partnerships, Small Business Innovation Research Program. Dr.DasGupta is currently the lead program director for the Innovation Corps (I-Corps) program. Beforejoining NSF, Dr. DasGupta was the chief scientist for CONTECH Division, SPX Corporation. Prior tojoining the industry, Dr. DasGupta held various professorships at the Milwaukee School of Engineering,UW-Madison, UW-Milwaukee, and Western Michigan University. Dr. DasGupta has received multipleawards and honors and has published numerous papers, has presented at various international and domesticconferences, and has five patents to his credit. In the summer of 1985, Dr. DasGupta was also invited as avisiting scientist to China Steel Corporation in Kaoshiung, Taiwan.2:30PM – 3:30PMNew Approaches to Innovation – Disruptive Technology Health InstituteAbandoning the old innovation model of launching a great idea into market is being challenged at CarnegieMellon University’s Disruptive Technology Health Institute. What can be learned from informationtechnology and data mining practices that can be useful and disruptive for chemical entrepreneurs taking amarket-first approach?Lynn M. Brusco, Executive Director, Disruptive Technology Health Institute, Carnegie Mellon University
3:30PM – 3:45PMBREAK & NETWORKING (NEA Auditorium Foyer)3:45PM – 4:30PMChallenges & Determination – Lessons from an EntrepreneurDr. David Harwell, ACS’s Administrator for the ACS Entrepreneurship Initiative, interviews Dr. Serrero aboutthe challenges she faced and the lessons she learned from starting her own company based on her discovery ofthe GP88/PGRN growth factor protein and her pioneering research demonstrating its importance in thetumorigenesis of many cancers.Dr. Ginette Serrero, CEO and Co-Founder of A&G PharmaceuticalsPHOTO & BIO – GINETTA04:30PM – 5:30PMUnique Partnerships in InnovationWhat is the latest in innovation from urban research parks? How is the nation’s oldest urban research parkresponding to the changes in innovation over the years? And, what does the future look like for research parksas the process of innovation changes.Dr. Stephen S. Tang, President & CEO, University City Science CenterPHOTO & BIO – STEPHEN TANG5:30PM – 7:00PMEVENING NETWORKING RECEPTION (ACS Hach Headquarters – Marvels)
DAY 2 – Tuesday, October 14, 2014(ACS Hach Headquarters – Marvel Halls)7:00AM – 8:30AMRegistration (Lobby)/Continental Breakfast (TBD)8:30AM – 8:40AMWelcoming RemarksACS’s Executive Director & CEO, Madeleine Jacobs, will open the Summit with welcoming remarks.8:40AM – 9:30AMGetting FundedACS's Innovation Counsel and Administrator to the ACS Entrepreneurial Resources Center, Kenneth Polk,interviews Dr. Mark Vreeke about his co-founding of the Chemical Angel Network; his experiences with thechallenges entrepreneurs face as they navigate investment discussions; and some pragmatic dos and don'ts thatmay help you, the entrepreneur, along a traditional funding path. To give us a perspective on emerging funding,Dr. Polk will interview Scott Popma about the latest in crowd funding activities as an alternative source offunding.Dr. Mark Vreeke, Co-Founder, Chemical Angel NetworkScott J. Popma: Founder, Ballast IP Capital GroupScott J. Popma is the founder of Ballast IP Capital Group and former partner at Finnegan, Henderson,Farabow, Garrett & Dunner, LLP’s Washington, D.C. office. He is an industry leader on issues surrounding theintersection of intellectual property law and emerging technologies and advises clients on a wide variety of IPlegal issues including licensing, crowdfunding, crowdsourcing, freedom to operate, portfolio and landscapeanalysis, litigation strategy, and monetization.9:30AM – 10:30AMThe Innovation Spotlight – E. I. du Pont de Nemours and CompanyWilliam D. Provine, Director, Science & Technology External Affairs, DuPont10:30AM – 11:00AMBREAK & NETWORKING (ACS Hach Headquarters – Marvel Halls)11:00AM – 12:00PMManaging Risk & Opportunity – Partners Ready to AssistRisk and opportunity go hand-in-hand. What is available to the chemical entrepreneurship from the riskmanagement community that will help to broaden opportunities for growth? This panel discusses why andhow insurance should be part of your operational planning.Moderator: Dr. Dennis Chamot, Member of the ACS Membership Insurance Board of Trustees, Past Memberof the ACS Board of Directors, Retired Member of the National Academies of Science.
Panelist:Dr. Henry Cifuentes, Hays Companies, Program Administrator for the ACS Professional LiabilityInsurance ProgramPanelist:Mr. Richard Kissel, Partner, Kissel Pesce Hirsch & Wilmer, LLP, Claims Attorney for the ACSProfessional Liability Plan for Lloyd’s of LondonPanelist:Mr. William Henson, Senior Select Customer Sales Representative, The Hartford, Key StaffMember of the ACS Commercial Business Insurance PlansRisk and opportunity go hand-in-hand. What is available to the chemical entrepreneurship from the riskmanagement community that will help to broaden opportunities for growth? This panel discusses why andhow insurance should be part of your operational planning.Moderator: Dr. Dennis Chamot, Member of the Board of Trustees, Group Insurance Plans for ACS Members.Dennis Chamot recently retired as Associate Executive Director of the Division on Engineering and Physical Systems of the NationalResearch Council. He had served as a member of the Board of Directors of the American Chemical Society for ten years, and was acandidate for President-Elect of the ACS in 2011. He is a Fellow of the ACS and of the American Association for the Advancement ofScience (AAAS). Dr. Chamot holds a Ph.D. (Chemistry) from the University of Illinois, and MBA from the Wharton School of theUniversity of Pennsylvania.Panelist: Mr. Henry Cifuentes, Hays Companies, Program Administrator/Underwriter for the ACSProgram.Professional Liability InsuranceHenry Cifuentes has thirteen years of Underwriting, Risk Management and Affinity Program underwriting and developmentexperience. Henry is currently Vice President at Hays Companies of Washington, D.C. He is responsible for casualty underwriting,business development and servicing a wide variety of affinity insurance programs and policyholders. Henry started his career at AON ofWashington, D.C. in the national programs division as an underwriter. Henry has successfully managed multiple national affinity programsand assisted in developing others from the ground up. Henry has specialized in underwriting and providing risk management servicesacross many professional service industries including Environmental, Health & Safety, Technology, Life Sciences, Accounting, Legal, andEngineering. Henry is also involved in the day-to-day operations and advising policyholders of their coverage terms and options. Henry isresponsible for working with national association clients to develop and maintain a high value insurance program. Henry Cifuentesgraduated with a B.S. Management from Virginia Tech and with an MBA from Marymount University.Panelist: Mr. Richard Kissel, Partner, Kissel Hirsch & Wilmer, LLP, Claims Attorney for the ACS Professional Liability Plan for Lloyd’sof London.Mr. Kissel is a founding member of Kissel Hirsch & Wilmer and has represented the interests of insurers and reinsurers for over 30 years.Rich graduated with honors from Syracuse University College of Law, where he was on the Moot Court Board, for which he receivedawards. He was also a Graduate Teaching Assistant in Legal Research and Writing. Rich graduated with honors from Boston UniversitySchool of Management, where he majored in accounting.Panelist: Mr. William Henson, Senior Sales Representative, The Hartford.Chip Henson is a graduate of Virginia Tech where he received a Bachelor of Science in Marketing. Following graduation in 2000, Chipentered the insurance industry with Liberty Mutual Insurance in sales and marketing. In 2008 Chip went to work for a large nationalinsurance brokerage, and ultimately transitioned to his current marketing role with The Hartford in 2012.12:00PM – 1:00PMNETWORKING LUNCH (ACS Hach Headquarters – Marvel Halls)01:00PM – 01:45PMChemical Innovation and EntrepreneurshipThis session discusses the role that corporate venture partners can play in the development of promisingchemical technologies through expertise, development arrangements, and funding.Moderator: Dr. Magid Abou-Gharbia, Associate Dean for Research, Laura H. Carnell Professor & Director ofthe Moulder Center for Drug Discovery Research, School of Pharmacy, Temple UniversityPanelist:Dr.Amy Ripka, Associate VP of Program Management, SAl Life Science LimitedPanelist:Dr. Dan Daly, Director of the AIME Center, University of Alabama
PHOTO & BIO – MAGID, AMY, DAN01:45PM – 02:30PMValidating the Technology – Role of Proof-of-Concept (POC) CentersProof-of-Concept Centers play a crucial role in validating the value proposition. The ability to create aprototype of the invention and test the prototype in a statistically designed experiment in which thedifferentiating qualities of the innovation can be demonstrated against competitive technologies is of greatvalue to potential investor’s assessment.Moderator: Dr. Dan Daly, Director of the AIME Center, University of AlabamaPanelist: Julie Weber, Battery Innovation CenterPanelist: Andrea Wesser, MegaWatt VenturesPanelist: Bryan Borlik, Director of Performance and National Programs EDA,Panelist: Richard Kordal, PhD, Director, Office of Intellectual Property and Commercialization LouisianaTech University2:30PM – 2:45PMBREAK & NETWORKING (ACS Hach Headquarters – Marvel Halls)02:45PM – 03:45PMCommercial Partners – The Best Way to a DealThis session discusses the driving needs for Big Pharma to collaborate more with external academics,entrepreneurs and biotechs on the deployment of novel chemistry platform technologies, development ofnovel therapeutic compounds and lower cost pharmaceuticals. The focus would be on how academics,entrepreneurs and small biotech’s should best go about making deals happen with pharma in the new biotechera.Moderator: Dr. Avi Spier, Director, Strategic Alliances, Novartis Institutes for BioMedical Research, Inc.03:45PM – 05:00PMPanelist:Dr. Julius Knowles, Partner, Innovation Fund, Partners HealthCarePanelist:Dr. Paul Stead, Director - Business Development, Platform Technology and Science, GSKPanelist:Dr. Jonas Niaura, Director, Search and Evaluation, AstraZenecaPanelist:Dr. Scott Forrest, VP, Business Development, The Scripps Research InstitutePanelist:Dr. Venkat Reddy, Senior Director, Strategic Alliances and Partnerships, Centers for TherapeuticInnovation (CTI) Pfizer Inc.Develop the Customer, Then the BusinessThis presentation will provide entrepreneurs with real experiences and strategies for finding and developingcustomers, determining their ability and willingness to pay, and building customer relationships.Moderator: Lynette Horton, former Managing Director, Harbert Management Corporation, Marketing &Investor RelationsPanelist:Ron Kreis, Founder & President, BiMax, Inc.Panelist:Dr. Ronald Pierantozzi, Managing Partner, Cameron and AssociatesPanelist:Dr. William Armiger, President, BioChemInsights, Inc.Dr. Ronald Pierantozzi, Managing Partner, Cameron and AssociatesDr. Pierantozzi,a technologist and inventor (Ph.D. Chemistry, 32 US Patents in the Chemicals and Materials Domain)bridges the space between business strategy and technology. He has developed business opportunities for both large and
small companies, serving as CEO of PPT Research, a high tech materials concern, board member for Primet PrecisionMaterials and an advisor to the Fortune 100 as well as start-ups. He continues to lecture on corporate entrepreneurship andinnovation at The Wharton Business School, RPI Lally School of Management, Babson college and the Danish TechnicalUniversity . He was also an executive with Air Products and Chemicals where he was responsible for Corporate Venturingand innovation. He has co-authored articles in both HBR and SMR.Dr, Ron Kreis, Founder & President, BiMax, Inc.Founded BiMax over 20 years ago. has grown the company from 2 to over 70 people today operating their chemical plant 24x7 makingspecialty polymers and monomers. They are a major supplier to the contact lens business world-wide as well as the developer and supplierof coating for cell phones and computer screens. Ron received his PhD in Chemistry from the University of Delaware. After 14 atAlcolac, Inc where he was Vice President of Technology, he started Bimax. His company has grown organically and occupies a uniqueniche in the specialty chemicals business. He will bring to the panel a wealth of experience in building an entrepreneurial chemicalbusiness.05:00PMSummit Closing & Concluding RemarksACS's Innovation Counsel and Administrator to the ACS Entrepreneurial Resources Center Kenneth Polkconcludes the Summit with closing remarks.
3:30PM - 3:45PM BREAK & NETWORKING (NEA Auditorium Foyer) 3:45PM - 4:30PM Challenges & Determination - Lessons from an Entrepreneur Dr. David Harwell, ACS's Administrator for the ACS Entrepreneurship Initiative, interviews Dr. Serrero about the challenges she faced and the lessons she learned from starting her own company based on her discovery of
